EV/EBITDA
-0.05
-0.01-25.00%
8 min ago
Summary
- As of February 24, 2025, RSLS EV/EBITDA is -0.05, with a fall of -0.01 (-25.00%) during the most recent trading day.
- Over the past year, RSLS EV/EBITDA has dropped by -0.09 (-225.00%).
- RSLS EV/EBITDA is now -105.43% below its all-time high of 0.92.
Performance
RSLS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
RSLS EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
todaytoday | -25.0% | +24.7% | +9.0% |
1 m1 month | +83.9% | -84.1% | -68.8% |
3 m3 months | +88.6% | -88.6% | -76.4% |
6 m6 months | +89.1% | -90.5% | -86.6% |
ytdytd | +83.9% | -83.8% | -68.4% |
1 y1 year | -225.0% | +167.7% | -85.1% |
5 y5 years | +99.8% | -100.0% | -100.0% |
RSLS EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | -25.0% | -0.33 | +84.8% | |
3 m | 3-month | -0.04 | -25.0% | -0.45 | +88.9% |
6 m | 6-month | -0.04 | -25.0% | -0.50 | +90.0% |
1 y | 1-year | 0.04 | -225.0% | -0.66 | +92.4% |
3 y | 3-year | 0.21 | -123.8% | -0.66 | +92.4% |
5 y | 5-year | 0.21 | -123.8% | -8184 | +100.0% |
alltime | all time | 0.92 | -105.4% | -8184 | +100.0% |
ReShape Lifesciences EV/EBITDA History
Date | Value |
---|---|
2025 | -0.05(-83.9%) |
2024 | -0.31(+158.3%) |
2023 | -0.12(-1300.0%) |
2022 | 0.01(-110.0%) |
2021 | -0.10(-100.0%) |
Date | Value |
---|---|
2020 | -1483.09(+4917.2%) |
2019 | -29.56(-74.2%) |
2018 | -114.55(>+9900.0%) |
2017 | -0.28(-264.7%) |
2016 | 0.17 |
FAQ
- What is ReShape Lifesciences EV/EBITDA?
- What is the all time high EV/EBITDA for ReShape Lifesciences?
- What is RSLS EV/EBITDA year-to-date change?
- What is ReShape Lifesciences EV/EBITDA year-on-year change?
What is ReShape Lifesciences EV/EBITDA?
The current EV/EBITDA of RSLS is -0.05
What is the all time high EV/EBITDA for ReShape Lifesciences?
ReShape Lifesciences all-time high EV/EBITDA is 0.92
What is RSLS EV/EBITDA year-to-date change?
ReShape Lifesciences EV/EBITDA has changed by +0.26 (+83.87%) since the beginning of the year
What is ReShape Lifesciences EV/EBITDA year-on-year change?
Over the past year, RSLS EV/EBITDA has changed by -0.09 (-225.00%)